Publication Cover
Inhalation Toxicology
International Forum for Respiratory Research
Volume 34, 2022 - Issue 11-12
104
Views
0
CrossRef citations to date
0
Altmetric
Research Articles

Arid2-IR downregulates miR-132-3p through methylation to promote LPS-induced ALI in pneumonia

, , &
Pages 297-303 | Received 12 Apr 2022, Accepted 13 Jul 2022, Published online: 08 Sep 2022

References

  • An X, Sun X, Hou Y, Yang X, Chen H, Zhang P, Wu J. 2019. Protective effect of oxytocin on LPS-induced acute lung injury in mice. Sci Rep. 9(1):2836.
  • Chen X, Liu Q, Chen J, Liu Y. 2021. LncRNA RP11-248E9.5 and RP11-456D7.1 are valuable for the diagnosis of childhood pneumonia. Int J Gen Med. 14:895–902.
  • Cillóniz C, Dominedò C, Torres A. 2019 Mar 9. Multidrug resistant Gram-negative bacteria in community-acquired pneumonia. Crit Care. 23(1):79.
  • Ebell MH, Chupp H, Cai X, Bentivegna M, Kearney M. 2020 Jul. Accuracy of signs and symptoms for the diagnosis of community-acquired pneumonia: a meta-analysis. Acad Emerg Med. 27(7):541–553.
  • Howie SRC, Murdoch DR. 2019 Jan. Global childhood pneumonia: the good news, the bad news, and the way ahead. Lancet Glob Health. 7(1):e4–e5.
  • Liu JH, Li C, Cao L, Zhang CH, Zhang ZH. 2021 Dec. Exosomal miR-132-3p from mesenchymal stem cells alleviated LPS-induced acute lung injury by repressing TRAF6. Autoimmunity 54(8):493–503.
  • Mandell LA, Niederman MS. 2019 Feb 14. Aspiration pneumonia. N Engl J Med. 380(7):651–663.
  • Quinton LJ, Walkey AJ, Mizgerd JP. 2018 Jul 1. Integrative physiology of pneumonia. Physiol Rev. 98(3):1417–1464.
  • Rawson TM, Moore LSP, Zhu N, Ranganathan N, Skolimowska K, Gilchrist M, et al. 2020. Bacterial and fungal coinfection in individuals with coronavirus: a rapid review to support COVID-19 antimicrobial prescribing. Clin Infect Dis. 71(9):2459–2468.
  • Shi H, Han X, Jiang N, Cao Y, Alwalid O, Gu J, Fan Y, Zheng C. 2020. Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study. Lancet Infect Dis. 20(4):425–434.
  • Shi J, Wang H, Liu J, Zhang Y, Luo J, Li Y, Yang C, Jiang J. 2020. Ganoderic acid B attenuates LPS-induced lung injury. Int Immunopharmacol. 88:106990.
  • Vaughn VM, Flanders SA, Snyder A, Conlon A, Rogers MAM, Malani AN, McLaughlin E, Bloemers S, Srinivasan A, Nagel J, et al. 2019. Excess antibiotic treatment duration and adverse events in patients hospitalized with pneumonia: a multihospital cohort study. Ann Intern Med. 171(3):153–163.
  • World Health Organization. 2014. Infection prevention and control of epidemic-and pandemic-prone acute respiratory infections in health care. World Health Organization.
  • Xiong WM, Xu QP, Xiao RD, Hu ZJ, Cai L, He F. 2019. Genome-wide DNA methylation and RNA expression profiles identified RIPK3 as a differentially methylated gene in Chlamydia pneumoniae infection lung carcinoma patients in China. Cancer Manag Res. 11:5785–5797.
  • Yu H, Chen Y, Jiang P. 2018. Circular RNA HIPK3 exerts oncogenic properties through suppression of miR-124 in lung cancer. Biochem Biophys Res Commun. 506(3):455–462.
  • Zhang D, Li X, Hu Y, Jiang H, Wu Y, Ding Y, Yu K, He H, Xu J, Sun L, et al. 2018. Tabersonine attenuates lipopolysaccharide-induced acute lung injury via suppressing TRAF6 ubiquitination. Biochem Pharmacol. 154:183–192.
  • Zhang P, Yu C, Yu J, Li Z, Lan HY, Zhou Q. 2021. Arid2-IR promotes NF-κB-mediated renal inflammation by targeting NLRC5 transcription. Cell Mol Life Sci. 78(5):2387–2404.
  • Zhou Q, Huang XR, Yu J, Yu X, Lan HY. 2015. Long noncoding RNA Arid2-IR is a novel therapeutic target for renal inflammation. Mol Ther. 23(6):1034–1043.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.